In response to the COVID-19 pandemic, all rheumatology fellowship interviews conducted in the 2020 fellowship recruitment season were conducted in a virtual, video-based format to reduce the risks associated with travel and face-to-face meetings. In June 2020, the Coalition for Physician Accountability released guidance suggesting all programs commit to online-only interviews and recruitment events, even…
Preparing for the American Board of Internal Medicine (ABIM) Rheumatology Certification Exam can easily be one of the most anxiety-inducing times for young trainees (and even seasoned rheumatologists). Once again, you are asked to demonstrate mastery of your knowledge in a medical field, and this time it is for the field of rheumatology—a discipline with…
Civil unrest in response to racism is a call for realignment of priorities in all aspects of society, including medical education. Hospital preparedness demands training in the treatment of victims of pepper spray, tear gas and rubber bullets, as well as planning for lockdown procedures in healthcare facilities and medical schools. Beyond logistics though, events…
I have been tongue-tied, of late. When I was a medical student, I was told not to turn the physical examination into an aerobic workout. This sage piece of advice was imparted by my physical examination preceptor, who had watched me perform a complete examination on a hapless volunteer. At the time, I thought of…
RheumMadness is an online collaborative learning experience created to educate trainees, rheumatologists and the wider medical community about recent advances and important concepts in rheumatology. The project is funded by the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award and modeled after NephMadness, an educational initiative of the American Journal of Kidney Diseases (AJKD) that…
(Reuters Health)—Among a group of New York patients with rheumatic diseases who received a SARS-CoV-2 vaccine, nearly one in six experienced disease flares after getting their shots, a new study finds.1 A survey of more than 1,100 patients who had received at least one vaccine dose revealed that 14.9% experienced flares. Among the 654 who…
Hesitancy about COVID-19 vaccination persists nationwide, although it varies among regions and sociodemographic groups.
Amid rising drug costs and the growing influence of pharmacy benefit managers on patient care decisions, physicians are increasingly called upon to advocate for affordable, evidence-based treatments for their patients.
Based on data from two phase 3 clinical trials, Health Canada has approved the use of upadacitinib to treat adults with active psoriatic arthritis.
In an efficacy and safety study of guselkumab, patients with active psoriatic arthritis taking guselkumab showed continued skin clearance and joint symptom relief, as well as statistically significant inhibition of joint damage, after two years.